Better Therapeutics, Inc.

Welcome to the Better Therapeutics Second Quarter 2023 update call. At this time, all participants are in a listen-only mode. After this speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press 411 on your telephone. You will then hear an automated message advising your hand is raised. And please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Mark Heinen, Chief Financial Officer. Please.

Thank you, operator.

Good afternoon, everyone, and welcome to the Better Therapeutics conference call. Our press release was issued this afternoon and can be found in the investor section of our corporate website, bettertx.com. Joining me on the call today is Frank Carbaugh, our president and chief executive officer, Dr. Mark Berman, our chief medical officer, and Diane Gomez-Dennis, our chief commercial officer. During today's call, we will provide a business update and a financial overview of the second quarter of 2023. A Q&A session will follow our prepared remarks. Before we begin, I'd like to remind everyone that any statements we make or information presented on this call that are not historical facts are forward-looking statements that are based on our current beliefs, plans, and expectations, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual events and results may differ materially from those expressed or implied by any forward-looking statements. With that, I'll pass the call over to Frank Carva. Frank?